CTLA4 and arthritic joint disease: Taken together, we speculate that in combined ICI arthritis, steroid-resistant Th17 cells, differentiated by CTLA-4 inhibitor therapy, might undergo plasticity into Th1 cells, which in turn help CD8+ T cells in arthritis-irAE.